Scinai Immunotherapeutics Ownership 2024 | Who Owns Scinai Immunotherapeutics Now?

OverviewChart

Institutional Ownership

1.12%

Insider Ownership

20.02%

Retail Ownership

78.86%

Institutional Holders

10.00

Scinai Immunotherapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.04%	0.61%	325,974	105,412	47.79%	704,104,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.01%	0.00%	43,604	43,604	100.00%	94,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	10,508	10,508	100.00%	23,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	5,322	5,022	1674.00%	11,496,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	2,257	-561	-19.91%	4,875,000	Mar 31, 2023
CREDIT AGRICOLE S A	0.00%	-	424	-	-	916,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	-	0.00%	160	-	-	345,600,000	Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC	-	-	50	-	-	95,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	20	-	-	43,000	Mar 31, 2023
NEWSQUARE CAPITAL LLC	-	-	2	-	-	4,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	-	-254	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-17,459	-100.00%	-	Mar 31, 2023

Scinai Immunotherapeutics's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 0.04% of the company's total share outstanding, currently valued at $704.10M. The top 10 institutional shareholders own together 0.05% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.04%	0.61%	325,974	105,412	47.79%	704,104,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	10,508	10,508	100.00%	23,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	-	0.00%	160	-	-	345,600,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.01%	0.00%	43,604	43,604	100.00%	94,000	Mar 31, 2023
CREDIT AGRICOLE S A	0.00%	-	424	-	-	916,000	Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC	-	-	50	-	-	95,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	5,322	5,022	1674.00%	11,496,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	2,257	-561	-19.91%	4,875,000	Mar 31, 2023
NEWSQUARE CAPITAL LLC	-	-	2	-	-	4,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	20	-	-	43,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	-	-254	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-17,459	-100.00%	-	Mar 31, 2023

The largest Scinai Immunotherapeutics shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 325.97K shares of Scinai Immunotherapeutics (BVXV), representing 0.61% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.04%	0.61%	325,974	105,412	47.79%	704,104,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.01%	0.00%	43,604	43,604	100.00%	94,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	10,508	10,508	100.00%	23,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	5,322	5,022	1674.00%	11,496,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	20	-	-	43,000	Mar 31, 2023
NEWSQUARE CAPITAL LLC	-	-	2	-	-	4,000	Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC	-	-	50	-	-	95,000	Mar 31, 2023
CREDIT AGRICOLE S A	0.00%	-	424	-	-	916,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	-	0.00%	160	-	-	345,600,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	-	-254	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.00%	-	2,257	-561	-19.91%	4,875,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-17,459	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Scinai Immunotherapeutics's largest institutional buyer is SABBY MANAGEMENT, LLC. The company purchased 105.41K stocks of BVXV, valued at $704.10M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	-	-	-	-17,459	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.00%	-	2,257	-561	-19.91%	4,875,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	-	-254	-100.00%	-	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	-	0.00%	160	-	-	345,600,000	Mar 31, 2023
CREDIT AGRICOLE S A	0.00%	-	424	-	-	916,000	Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC	-	-	50	-	-	95,000	Mar 31, 2023
NEWSQUARE CAPITAL LLC	-	-	2	-	-	4,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	20	-	-	43,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	5,322	5,022	1674.00%	11,496,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	10,508	10,508	100.00%	23,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.01%	0.00%	43,604	43,604	100.00%	94,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	0.04%	0.61%	325,974	105,412	47.79%	704,104,000	Mar 31, 2023

As of Mar 31 2023, Scinai Immunotherapeutics's biggest institutional seller is CITADEL ADVISORS LLC. The company sold -17.46K shares of BVXV, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	0.01%	0.00%	43,604	43,604	100.00%	94,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	10,508	10,508	100.00%	23,000	Mar 31, 2023

Scinai Immunotherapeutics's largest new institutional shareholder by number of shares is MILLENNIUM MANAGEMENT LLC, purchased 43.60K shares, valued at $94.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	-	-	-	-17,459	-100.00%	-	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	-	-254	-100.00%	-	Mar 31, 2023

Scinai Immunotherapeutics's largest sold out institutional shareholder by shares sold is CITADEL ADVISORS LLC, sold -17.46K shares, valued at -, as of undefined.

Scinai Immunotherapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Ark ETF Trust	0.00%	9,720	-	-	Jan 31, 2024
TRUST FOR PROFESSIONAL MANAGERS	0.00%	163,423	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	13,768	-	-	Feb 29, 2024
TRUST FOR PROFESSIONAL MANAGERS	0.00%	7,921	-	-	Feb 29, 2024
SPDR INDEX SHARES FUNDS	0.00%	294	-	-	Mar 31, 2024

Scinai Immunotherapeutics's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 9.72K shares, compromising 0.00% of its total assets.

Scinai Immunotherapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	10	-23.08%
30 Jun, 22	13	-23.53%
31 Mar, 22	17	30.77%
31 Dec, 21	13	-13.33%
30 Sep, 21	15	-
30 Jun, 21	15	-11.76%
31 Mar, 21	17	54.55%
31 Dec, 20	11	-38.89%
30 Sep, 20	18	28.57%
30 Jun, 20	14	75.00%
31 Mar, 20	8	-27.27%
31 Dec, 19	11	37.50%
30 Sep, 19	8	14.29%
30 Jun, 19	7	-22.22%
31 Mar, 19	9	-10.00%
31 Dec, 18	10	-9.09%
30 Sep, 18	11	-8.33%
30 Jun, 18	12	-14.29%
31 Mar, 18	14	27.27%
31 Dec, 17	11	37.50%
30 Sep, 17	8	60.00%
30 Jun, 17	5	-16.67%
31 Mar, 17	6	100.00%
31 Dec, 16	3	-
30 Sep, 16	3	-
30 Jun, 16	3	-
31 Mar, 16	3	50.00%
31 Dec, 15	2	-60.00%
30 Sep, 15	5	-
30 Jun, 15	5	-

As of 30 Sep 22, 10 institutions are holding Scinai Immunotherapeutics's shares, representing a decrease of -23.08% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	209,678	-37.19%
30 Jun, 22	333,826	1.10%
31 Mar, 22	330,182	-1.77%
31 Dec, 21	336,148	31.98%
30 Sep, 21	254,693	-18.18%
30 Jun, 21	311,298	9.76%
31 Mar, 21	283,618	27.93%
31 Dec, 20	221,696	-58.90%
30 Sep, 20	539,410	6.54%
30 Jun, 20	506,304	25.12%
31 Mar, 20	404,641	-15.16%
31 Dec, 19	476,959	17.43%
30 Sep, 19	406,168	0.12%
30 Jun, 19	405,671	-2.80%
31 Mar, 19	417,344	-6.51%
31 Dec, 18	446,384	-0.53%
30 Sep, 18	448,784	-1.89%
30 Jun, 18	457,447	-3.85%
31 Mar, 18	475,746	-4.13%
31 Dec, 17	496,218	367.12%
30 Sep, 17	106,230	272.78%
30 Jun, 17	28,497	-60.87%
31 Mar, 17	72,819	86.72%
31 Dec, 16	39,000	20.05%
30 Sep, 16	32,486	-2.72%
30 Jun, 16	33,393	1.83%
31 Mar, 16	32,793	2.48%
31 Dec, 15	32,000	-33.55%
30 Sep, 15	48,159	-51.86%
30 Jun, 15	100,047	-

Scinai Immunotherapeutics (BVXV) has 209.68K shares outstanding as of 30 Sep 22, down -37.19% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	1.12%	35.12%
30 Jun, 22	1.79%	33.31%
31 Mar, 22	2.32%	40.84%
31 Dec, 21	2.38%	75.40%
30 Sep, 21	1.78%	37.67%
30 Jun, 21	2.17%	47.56%
31 Mar, 21	2.14%	76.58%
31 Dec, 20	1.67%	7.63%
30 Sep, 20	4.68%	21.44%
30 Jun, 20	4.67%	29.77%
31 Mar, 20	3.96%	18.17%
31 Dec, 19	4.67%	25.26%
30 Sep, 19	4.30%	11.16%
30 Jun, 19	6.21%	15.22%
31 Mar, 19	6.39%	13.69%
31 Dec, 18	6.83%	14.49%
30 Sep, 18	6.87%	14.02%
30 Jun, 18	7.00%	13.21%
31 Mar, 18	7.28%	12.63%
31 Dec, 17	7.59%	154.24%
30 Sep, 17	2.22%	527.75%
30 Jun, 17	0.65%	20.18%
31 Mar, 17	1.79%	134.45%
31 Dec, 16	1.15%	124.81%
30 Sep, 16	0.96%	98.39%
30 Jun, 16	0.99%	104.88%
31 Mar, 16	0.97%	65.99%
31 Dec, 15	1.21%	59.66%
30 Sep, 15	1.43%	8.25%
30 Jun, 15	4.16%	-

As of 30 Sep 22, Scinai Immunotherapeutics is held by 1.12% institutional shareholders, representing a 35.12% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	3	-25.00%
30 Jun, 22	4	-63.64%
31 Mar, 22	11	57.14%
31 Dec, 21	7	16.67%
30 Sep, 21	6	-25.00%
30 Jun, 21	8	-
31 Mar, 21	8	14.29%
31 Dec, 20	7	-50.00%
30 Sep, 20	14	27.27%
30 Jun, 20	11	120.00%
31 Mar, 20	5	66.67%
31 Dec, 19	3	200.00%
30 Sep, 19	1	-
30 Jun, 19	1	-
31 Mar, 19	1	-50.00%
31 Dec, 18	2	-
30 Sep, 18	2	-
30 Jun, 18	-	-100.00%
31 Mar, 18	5	-37.50%
31 Dec, 17	8	14.29%
30 Sep, 17	7	250.00%
30 Jun, 17	2	-50.00%
31 Mar, 17	4	300.00%
31 Dec, 16	1	-
30 Sep, 16	1	-
30 Jun, 16	1	-
31 Mar, 16	1	-
31 Dec, 15	-	-100.00%
30 Sep, 15	3	-40.00%
30 Jun, 15	5	-

3 institutional shareholders have increased their position in BVXV stock as of 30 Sep 22 compared to 4 in the previous quarter (a -25.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	3	-25.00%
30 Jun, 22	4	300.00%
31 Mar, 22	1	-
31 Dec, 21	1	-66.67%
30 Sep, 21	3	200.00%
30 Jun, 21	1	-66.67%
31 Mar, 21	3	50.00%
31 Dec, 20	2	-50.00%
30 Sep, 20	4	100.00%
30 Jun, 20	2	-
31 Mar, 20	2	100.00%
31 Dec, 19	1	-
30 Sep, 19	1	-
30 Jun, 19	-	-100.00%
31 Mar, 19	1	-50.00%
31 Dec, 18	2	-
30 Sep, 18	2	-
30 Jun, 18	2	-50.00%
31 Mar, 18	4	-
31 Dec, 17	-	-
30 Sep, 17	-	-100.00%
30 Jun, 17	1	-
31 Mar, 17	-	-100.00%
31 Dec, 16	1	-
30 Sep, 16	-	-
30 Jun, 16	-	-
31 Mar, 16	-	-
31 Dec, 15	-	-100.00%
30 Sep, 15	2	-
30 Jun, 15	-	-

3 institutional shareholders have reduced their position in BVXV stock as of 30 Sep 22 compared to 4 in the previous quarter (a -25.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	10	-23.08%	209,678	-37.19%	1.12%	35.12%	3	-25.00%	3	-25.00%
30 Jun, 22	13	-23.53%	333,826	1.10%	1.79%	33.31%	4	-63.64%	4	300.00%
31 Mar, 22	17	30.77%	330,182	-1.77%	2.32%	40.84%	11	57.14%	1	-
31 Dec, 21	13	-13.33%	336,148	31.98%	2.38%	75.40%	7	16.67%	1	-66.67%
30 Sep, 21	15	-	254,693	-18.18%	1.78%	37.67%	6	-25.00%	3	200.00%
30 Jun, 21	15	-11.76%	311,298	9.76%	2.17%	47.56%	8	-	1	-66.67%
31 Mar, 21	17	54.55%	283,618	27.93%	2.14%	76.58%	8	14.29%	3	50.00%
31 Dec, 20	11	-38.89%	221,696	-58.90%	1.67%	7.63%	7	-50.00%	2	-50.00%
30 Sep, 20	18	28.57%	539,410	6.54%	4.68%	21.44%	14	27.27%	4	100.00%
30 Jun, 20	14	75.00%	506,304	25.12%	4.67%	29.77%	11	120.00%	2	-
31 Mar, 20	8	-27.27%	404,641	-15.16%	3.96%	18.17%	5	66.67%	2	100.00%
31 Dec, 19	11	37.50%	476,959	17.43%	4.67%	25.26%	3	200.00%	1	-
30 Sep, 19	8	14.29%	406,168	0.12%	4.30%	11.16%	1	-	1	-
30 Jun, 19	7	-22.22%	405,671	-2.80%	6.21%	15.22%	1	-	-	-100.00%
31 Mar, 19	9	-10.00%	417,344	-6.51%	6.39%	13.69%	1	-50.00%	1	-50.00%
31 Dec, 18	10	-9.09%	446,384	-0.53%	6.83%	14.49%	2	-	2	-
30 Sep, 18	11	-8.33%	448,784	-1.89%	6.87%	14.02%	2	-	2	-
30 Jun, 18	12	-14.29%	457,447	-3.85%	7.00%	13.21%	-	-100.00%	2	-50.00%
31 Mar, 18	14	27.27%	475,746	-4.13%	7.28%	12.63%	5	-37.50%	4	-
31 Dec, 17	11	37.50%	496,218	367.12%	7.59%	154.24%	8	14.29%	-	-
30 Sep, 17	8	60.00%	106,230	272.78%	2.22%	527.75%	7	250.00%	-	-100.00%
30 Jun, 17	5	-16.67%	28,497	-60.87%	0.65%	20.18%	2	-50.00%	1	-
31 Mar, 17	6	100.00%	72,819	86.72%	1.79%	134.45%	4	300.00%	-	-100.00%
31 Dec, 16	3	-	39,000	20.05%	1.15%	124.81%	1	-	1	-
30 Sep, 16	3	-	32,486	-2.72%	0.96%	98.39%	1	-	-	-
30 Jun, 16	3	-	33,393	1.83%	0.99%	104.88%	1	-	-	-
31 Mar, 16	3	50.00%	32,793	2.48%	0.97%	65.99%	1	-	-	-
31 Dec, 15	2	-60.00%	32,000	-33.55%	1.21%	59.66%	-	-100.00%	-	-100.00%
30 Sep, 15	5	-	48,159	-51.86%	1.43%	8.25%	3	-40.00%	2	-
30 Jun, 15	5	-	100,047	-	4.16%	-	5	-	-	-

Scinai Immunotherapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Jan 23, 2023	MARGOLIN YAEL	director	-	Sell	133,200	-	-	-
Jan 23, 2023	MARGOLIN YAEL	director	-	Sell	-	-	-	66,800
Jan 23, 2023	Laster Morris C	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Laster Morris C	director	-	Sell	-	-	-	66,800
Jan 23, 2023	Lowell George	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Lowell George	director	-	Sell	-	-	-	421,680
Jan 23, 2023	Rotman Avner	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Rotman Avner	director	-	Sell	-	-	-	138,780
Jan 23, 2023	Rotman Avner	director	-	Sell	-	-	-	66,800
Jan 05, 2023	Moed Samuel J	director	-	Sell	3,280,000	$0.17	$570.72K	-
Jan 03, 2023	Green Jay	director	-	Sell	1,000,000	$0.07	$73.00K	-
Jan 03, 2023	MARGOLIN YAEL	director	-	Sell	133,200	-	-	-
Jan 03, 2023	MARGOLIN YAEL	director	-	Sell	-	-	-	66,800
Jan 03, 2023	Ben-Or Uri	officer	Chief Financial Officer	Sell	830,000	-	-	-
Jan 03, 2023	Ben-Yedidia Tamar	officer	Chief Scientist	Sell	1,500,000	-	-	-
Jan 03, 2023	Laster Morris C	director	-	Sell	1,000,000	$1.74	$1.74M	-
Jan 03, 2023	Laster Morris C	director	-	Sell	-	-	-	66,800
Jan 03, 2023	GERMAIN MARK	director	-	Sell	6,400,000	$0.17	$1.11M	-
Jan 03, 2023	Lowell George	director	-	Sell	133,200	-	-	-
Jan 03, 2023	Lowell George	director	-	Sell	-	-	-	421,680

All Insider Owners Trades

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Jan 23, 2023	MARGOLIN YAEL	director	-	Sell	133,200	-	-	-
Jan 23, 2023	MARGOLIN YAEL	director	-	Sell	-	-	-	66,800
Jan 23, 2023	Laster Morris C	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Laster Morris C	director	-	Sell	-	-	-	66,800
Jan 23, 2023	Lowell George	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Lowell George	director	-	Sell	-	-	-	421,680
Jan 23, 2023	Rotman Avner	director	-	Sell	133,200	-	-	-
Jan 23, 2023	Rotman Avner	director	-	Sell	-	-	-	138,780
Jan 23, 2023	Rotman Avner	director	-	Sell	-	-	-	66,800
Jan 05, 2023	Moed Samuel J	director	-	Sell	3,280,000	$0.17	$570.72K	-
Jan 03, 2023	Green Jay	director	-	Sell	1,000,000	$0.07	$73.00K	-
Jan 03, 2023	MARGOLIN YAEL	director	-	Sell	133,200	-	-	-
Jan 03, 2023	MARGOLIN YAEL	director	-	Sell	-	-	-	66,800
Jan 03, 2023	Ben-Or Uri	officer	Chief Financial Officer	Sell	830,000	-	-	-
Jan 03, 2023	Ben-Yedidia Tamar	officer	Chief Scientist	Sell	1,500,000	-	-	-
Jan 03, 2023	Laster Morris C	director	-	Sell	1,000,000	$1.74	$1.74M	-
Jan 03, 2023	Laster Morris C	director	-	Sell	-	-	-	66,800
Jan 03, 2023	GERMAIN MARK	director	-	Sell	6,400,000	$0.17	$1.11M	-
Jan 03, 2023	Lowell George	director	-	Sell	133,200	-	-	-
Jan 03, 2023	Lowell George	director	-	Sell	-	-	-	421,680

The last insider sell of Scinai Immunotherapeutics's stock was made by MARGOLIN YAEL on Jan 23 2023, selling 133,200 shares at - per share (valued at -).

Scinai Immunotherapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2031	-	1	-
Q1 2025	-	2	-
Q4 2024	-	1	-
Q1 2023	-	23	-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Scinai Immunotherapeutics's insiders, as of Q1 2031.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2031	-	-	-
Q1 2025	-	-	-
Q4 2024	-	-	-
Q1 2023	-	-	-

As of Q1 2031, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Scinai Immunotherapeutics's stocks.

Scinai Immunotherapeutics Peer Ownership

Ticker	Company
GOVX	GeoVax Labs, Inc.
ADIL	Adial Pharmaceuticals, Inc.
RVPH	Reviva Pharmaceuticals Holdings, Inc.
MLYS	Mineralys Therapeutics, Inc.
MDWD	MediWound Ltd.
SABS	SAB Biotherapeutics, Inc.
KTTA	Pasithea Therapeutics Corp.
ONCT	Oncternal Therapeutics, Inc.
ADTX	Aditxt, Inc.
BLRX	BioLineRx Ltd.
RNAZ	TransCode Therapeutics, Inc.
SRZN	Surrozen, Inc.
FWBI	Entero Therapeutics, Inc.
VCNX	Vaccinex, Inc.
ANTX	AN2 Therapeutics, Inc.
PHVS	Pharvaris N.V.
ORMP	Oramed Pharmaceuticals Inc.
PEPG	PepGen Inc.
SLRX	Salarius Pharmaceuticals, Inc.
ATXI	Avenue Therapeutics, Inc.
MOLN	Molecular Partners AG

BVXV Ownership FAQ

Who Owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics is owned by institutional shareholders (1.12%), insiders (20.02%), and public (78.86%). The largest institutional shareholder of Scinai Immunotherapeutics is SABBY MANAGEMENT, LLC (0.04% of total shares) and the top mutual fund owner is Ark ETF Trust (0.00% of total shares).

Who are the major institutional shareholders of Scinai Immunotherapeutics?

Scinai Immunotherapeutics's major institutional shareholders are SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VIRTU FINANCIAL LLC, UBS GROUP AG, and MORGAN STANLEY. The top five shareholders own together 0.05% of the company's share outstanding.

How many Scinai Immunotherapeutics shareholders are there?

As of Sep 2022, there are 10 institutional shareholders of Scinai Immunotherapeutics.

What percentage of Scinai Immunotherapeutics is owned by SABBY MANAGEMENT, LLC?

SABBY MANAGEMENT, LLC owns 325.97K shares of Scinai Immunotherapeutics, representing 0.04% of the company's total shares outstanding, valued at $704.1M (as of Mar 2023).

What percentage of Scinai Immunotherapeutics is owned by MILLENNIUM MANAGEMENT LLC?

As of Mar 2023, MILLENNIUM MANAGEMENT LLC holds 43.6K shares of Scinai Immunotherapeutics (BVXV), compromising 0.01% of the company, valued at $94K.

What percentage of Scinai Immunotherapeutics is owned by VIRTU FINANCIAL LLC?

VIRTU FINANCIAL LLC is the third largest holder of Scinai Immunotherapeutics. The company owns 10.51K of the company's shares outstanding (worth $23K).